Menu
Request a demo

Our products

An agile launch execution platform, with full visibility across countries and functions.
A collaborative platform for teams who plan reimbursements and HTA activities.
A collaborative platform designed to manage pharmaceutical tenders across countries.
A capability management platform that unifies capabilities, resources, and assessment.

Our expertise

Launch Readiness

Market Access

Tender Management

Featured Post

5 Pharma Trends for 2023: Challenges and opportunities in the post-COVID landscape

  • Andre Moa
  • 8 Dec 2022
  • 54 minute read

Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.

Read more

Latest posts

7 pharma trends for 2017 that will define the industry

From pricing concerns, reputational damage control, Trumpian uncertainty, technology convergence to multichannel, we predict the key pharma trends for 2017.

Read more

How are we doing? Tracking pharma product launch ROI through global and local challenges

Pharmaceutical companies must ensure that each component of their product launch plan makes a meaningful contribution to return on investment (ROI).

Read more

Maintaining pharma ROI as market access bites

By optimising the efficiency and impact of a launch programme, you can maintain ROI from new products at realistic levels that will keep R&D ticking over and continue providing incentives for pharma companies and their investors to pursue better health outcomes.

Read more

Making launches count: pharma ROI under strain

Medicines need to make a profit. Making launches count: pharma and biotech ROI under strain

Read more

8 pharma trends to keep top of mind in 2016

We predict the top pharma trends for 2016 including creative new approaches to drug pricing and reimbursement and building a digital-health ecosystem.

Read more

3 local launch risks your global team can’t afford to ignore

Market access is all about fine-tuning global plans to local demands. How do you stay on top of launch risks as your new product rolls out internationally?

Read more

Why leave launch risks in pharma to chance?

Launch risks are a fact of life when new drugs come to market. How do you ensure those risks stay visible and manageable across your organisation?

Read more

Can you afford to disregard pharma launch readiness tools used by your peers?

With marginal returns on new product launches, a revolution in the digital tools that support pharma launch readiness has taken place.

Read more

8 pharma trends that will shape the industry in 2015

From technology to transparency, collaboration to acquisitions, we predict the key pharma trends of 2015 that will affect the industry.

Read more

Are you allowing the talent in your launch team to shine?

Your global launch team is one of your best assets, but are they wasting time with too many admin tasks? Find out how to make your talent shine.

Read more

5 signs your launch team is not collaborating effectively

Collaboration is a key pillar of a successful pharma launch - watch out for these 5 signs that your launch team is not collaborating effectively.

Read more

3 ways to get more value from your global value dossier

Global value dossiers are the key to getting your products to market but when they’re done badly, they waste valuable time and resource.

Read more

Recent Posts

Most Popular Posts

Categories

Get our latest
posts in your inbox

TRiBECA Knowledge needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice.